NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1851619407
Verify on CMS → Nima Rezaei Abbassi
Ophthalmology Physician in Huntington Beach, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
5K
Medicare Part D claims · 1K beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$20.55
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Nima Rezaei Abbassi filed 5,204 Medicare Part D claims in 2023 as an Ophthalmology Physician in Huntington Beach, California, prescribing 58% generic.
- 5K
- Part D claims, 2023
- 58%
- generic prescribing
- $20.55
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Nima Rezaei Abbassi's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
5,204 Top 6% higher than 94% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
◑
Board-eligible specialty (heuristic, not verified)
Nima Rezaei Abbassi practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Nima Rezaei Abbassi?
Quality data not reportedPrimary specialty
Ophthalmology Physician
Medicare Part D claims
5,204 266% vs specialty avg
Specialty distribution in California
How Ophthalmology Physician compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ophthalmology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Nima Rezaei Abbassi appears in the CMS NPPES registry as an Ophthalmology Physician provider at 7677 CENTER AVE, Huntington Beach, CA, 92647, with a listed phone of (714) 901-2007. NPI 1851619407 was issued on 05/06/2010.
Medicare Part D records for calendar year 2023 show 5,204 prescription claims written by this provider, covering 1,241 Medicare beneficiaries and totaling roughly $561K in drug spend, split 42% brand-name and 58% generic by claim count.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1851619407 |
|---|---|
| Specialty | Ophthalmology Physician |
| Gender | Male |
| NPI Issued | 05/06/2010 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Nima Rezaei Abbassi. Source: openpaymentsdata.cms.gov.
Total received
$21
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Nima Rezaei Abbassi. To verify Nima Rezaei Abbassi's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Nima Rezaei Abbassi - brand share 42.0%
Ophthalmology Physician average
42% brand-name claims vs 58% generic, on 5,204 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
5,204
Total Claims
$561K
Total Drug Cost
1,241
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 7,810
- Total Day Supply
- 210,676
- Brand vs Generic
- 42% brand / 58% generic
- Brand Drug Cost
- $462K
- Generic Drug Cost
- $99K
Patient Demographics
- Average Patient Age
- 74.8 years
- Avg HCC Risk Score
- 1.71
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 52, 65-74: 579, 75-84: 466, 85+: 144
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Nima Rezaei Abbassi prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
1,200 claims
- Prednisolone Acetate
Prednisolone Acetate
903 claims
- Moxifloxacin
Moxifloxacin
668 claims
- Brimonidine Tartrate
Brimonidine Tartrate
593 claims
- Dorzolamide-Timolol 384
Dorzolamide-Timolol
384 claims
- Timolol Maleate 265
Timolol Maleate
265 claims
- Dorzolamide Hcl 133
Dorzolamide Hcl
133 claims
- Restasis 131
Restasis
131 claims
| Drug | Claims |
|---|---|
| Latanoprost | 1,200 |
| Prednisolone Acetate | 903 |
| Moxifloxacin Moxifloxacin Hcl | 668 |
| Brimonidine Tartrate | 593 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 384 |
| Timolol Maleate | 265 |
| Dorzolamide Hcl | 133 |
| Restasis Cyclosporine | 131 |
| Rhopressa Netarsudil Mesylate | 121 |
| Cyclosporine | 120 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Nima Rezaei Abbassi fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Nima Rezaei Abbassi's 5,204 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Rezaei Abbassi.
Dr. Sam Abbassi
MD, MS
West Hills, CA
Dr. Richard Abbott
M.D.
San Francisco, CA
Dr. Nizar Abdelfattah
MD
Pasadena, CA
Dr. Parastou Abedi
MD
Aliso Viejo, CA
Dr. Shahla Abedi
MD
Aliso Viejo, CA
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Nima Rezaei Abbassi's specialty? ▼
Nima Rezaei Abbassi specializes in Ophthalmology Physician and practices in Huntington Beach, California.
How much does Nima Rezaei Abbassi prescribe under Medicare Part D? ▼
In 2023, Nima Rezaei Abbassi wrote 5,204 Medicare Part D claims totaling $561K in drug costs for 1,241 beneficiaries.
Where is Nima Rezaei Abbassi located? ▼
Nima Rezaei Abbassi is located at 7677 CENTER AVE, Huntington Beach, CA, 92647. Phone: (714) 901-2007.
What is Nima Rezaei Abbassi's NPI number? ▼
Nima Rezaei Abbassi's National Provider Identifier (NPI) is 1851619407, issued on 05/06/2010.
Does Nima Rezaei Abbassi prescribe more brand-name or generic drugs? ▼
Nima Rezaei Abbassi's prescribing is 42% brand-name and 58% generic drugs by claim count, with $462K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Nima Rezaei Abbassi prescribe most often? ▼
Based on 2023 Medicare Part D data, Nima Rezaei Abbassi's most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Moxifloxacin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Nima Rezaei Abbassi accept Medicare? ▼
Nima Rezaei Abbassi appears in CMS Medicare data with 5,204 Part D claims and 1,241 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Nima Rezaei Abbassi's credentials? ▼
Nima Rezaei Abbassi's NPI is 1851619407. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.